Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€265.70

€265.70

1.550%
4.05
1.550%
?
 
16:45 / Tradegate WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Dexcom Inc. Stock

Dexcom Inc. gained 1.550% today.
The community is currently still undecided about Dexcom Inc. with 2 Buy predictions and 0 Sell predictions.
With a target price of €440.00 there is a hugely positive potential of 65.600% for Dexcom Inc. compared to the current price of €265.70.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.

Pros and Cons of Dexcom Inc. in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Dexcom Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Dexcom Inc. 1.550% -12.345% -34.275% -10.024% -44.706% 148.009% 322.835%
Zimmer Holdings -1.030% 1.456% -3.173% -16.169% -0.115% 8.807% 5.701%
Becton, Dickinson & Co. 0.300% -0.021% -1.064% 19.361% 6.158% 12.586% 42.125%
Dentsply Sirona Inc. 0.950% 3.364% -5.058% -33.622% -27.039% -24.356% -35.193%

Comments

Buy Dexcom Inc.
Show more

News

Dexcom Announces Upcoming Conference Presentation: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentation


DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and Diabetes Symposium on

Dexcom Announces Upcoming Conference Presentations: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor

Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time


DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.m. (Eastern Time). The